SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-044870
Filing Date
2021-02-16
Accepted
2021-02-16 16:09:28
Documents
1
Group Members
KEVIN P. STARRMARK LEVINROBERT I. TEPPERTHIRD ROCK VENTURES GP II, L.P.THIRD ROCK VENTURES GP III, L.P.THIRD ROCK VENTURES GP IV, L.P.THIRD ROCK VENTURES II, L.P.THIRD ROCK VENTURES IV, L.P.TRV GP II, LLCTRV GP III, LLCTRV GP IV, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d121186dsc13g.htm SC 13G 264490
  Complete submission text file 0001193125-21-044870.txt   266370
Mailing Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116
Business Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116 617-585-2000
Third Rock Ventures III, L.P. (Filed by) CIK: 0001569705 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Subject) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91387 | Film No.: 21638344
SIC: 2836 Biological Products, (No Diagnostic Substances)